Kirsten A. Kulcsar
Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection
Kulcsar, Kirsten A.; Coleman, Christopher M.; Beck, Sarah E.; Frieman, Matthew B.
Authors
Dr CHRISTOPHER COLEMAN CHRISTOPHER.COLEMAN@NOTTINGHAM.AC.UK
ASSISTANT PROFESSOR OF INFECTION IMMUNOLOGY
Sarah E. Beck
Matthew B. Frieman
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012 in Saudi Arabia and has caused over 2400 cases and more than 800 deaths. Epidemiological studies identified diabetes as the primary comorbidity associated with severe or lethal MERS-CoV infection. Understanding how diabetes affects MERS is important because of the global burden of diabetes and pandemic potential of MERS-CoV. We used a model in which mice were made susceptible to MERS-CoV by expressing human DPP4, and type 2 diabetes was induced by administering a high-fat diet. Upon infection with MERS-CoV, diabetic mice had a prolonged phase of severe disease and delayed recovery that was independent of virus titers. Histological analysis revealed that diabetic mice had delayed inflammation, which was then prolonged through 21 days after infection. Diabetic mice had fewer inflammatory monocyte/macrophages and CD4+ T cells, which correlated with lower levels of Ccl2 and Cxcl10 expression. Diabetic mice also had lower levels of Tnfa, Il6, Il12b, and Arg1 expression and higher levels of Il17a expression. These data suggest that the increased disease severity observed in individuals with MERS and comorbid type 2 diabetes is likely due to a dysregulated immune response, which results in more severe and prolonged lung pathology.
Citation
Kulcsar, K. A., Coleman, C. M., Beck, S. E., & Frieman, M. B. (2019). Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI insight, 4(20), 1-18. https://doi.org/10.1172/jci.insight.131774
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 18, 2019 |
Online Publication Date | Oct 17, 2019 |
Publication Date | Oct 17, 2019 |
Deposit Date | Dec 17, 2019 |
Publicly Available Date | Dec 18, 2019 |
Journal | JCI Insight |
Electronic ISSN | 2379-3708 |
Peer Reviewed | Peer Reviewed |
Volume | 4 |
Issue | 20 |
Pages | 1-18 |
DOI | https://doi.org/10.1172/jci.insight.131774 |
Public URL | https://nottingham-repository.worktribe.com/output/3589497 |
Publisher URL | https://insight.jci.org/articles/view/131774 |
Files
Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection
(5.2 Mb)
PDF
You might also like
Antiviral activity of salt-coated materials against SARS-CoV-2
(2023)
Journal Article
Experimental Investigation of a MopFan-Based Photocatalytic Air Purification Device
(2022)
Journal Article
Testing bats in rehabilitation for SARS-CoV-2 before release into the wild
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search